Reply to Lacout et al., “Value of Patient Population Selection and Lyme Borreliosis Tests”
暂无分享,去创建一个
L. Moravcová | M. Malý | P. Kodym | D. Pícha | D. Smíšková | Z. Kurzová | Dagmar Berenová
[1] P. Marcy,et al. Value of Patient Population Selection and Lyme Borreliosis Tests , 2019, Journal of Clinical Microbiology.
[2] L. Moravcová,et al. Serological Diagnostics of Lyme Borreliosis: Comparison of Universal and Borrelia Species-Specific Tests Based on Whole-Cell and Recombinant Antigens , 2018, Journal of Clinical Microbiology.
[3] H. Roháčová,et al. [Guideline for the diagnosis and treatment of Lyme borreliosis]. , 2018, Klinicka mikrobiologie a infekcni lekarstvi.
[4] Alison W. Rebman,et al. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome , 2017, Front. Med..
[5] G Stanek,et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] V. Fingerle,et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis , 2010, European journal of neurology.